Getinge AB Unsponsored ADR logo

Getinge AB Unsponsored ADR (GTN0)

Market Open
11 Aug, 06:02
XMUN XMUN
21. 60
0
0%
4.82B Market Cap
24.02 P/E Ratio
1.67% Div Yield
0 Volume
0 Eps
21.6
Previous Close
Add Transaction
Day Range
21.6 21.6
Year Range
16.8 21.6
Want to track GTN0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GTN0 trading today higher at €21.6, an increase of 0% from yesterday's close, completing a monthly increase of 21.3483% or €3.8. Over the past 12 months, GTN0 stock gained 6.9307%.
GTN0 pays dividends to its shareholders, with the most recent payment made on Apr 30, 2026.
The last earnings report, released on Apr 20, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.1857%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

GTN0 Chart

People also search for

CHY
ChemoMetec A/S
62.35
+8.7184%
Getinge AB (publ) (GNGBY) Q2 2026 Earnings Call Transcript

Getinge AB (publ) (GNGBY) Q2 2026 Earnings Call Transcript

Getinge AB (publ) (GNGBY) Q2 2026 Earnings Call Transcript

Seekingalpha | 3 weeks ago
Getinge AB (publ) (GNGBY) Q4 2025 Earnings Call Transcript

Getinge AB (publ) (GNGBY) Q4 2025 Earnings Call Transcript

Getinge AB (publ) (GNGBY) Q4 2025 Earnings Call Transcript

Seekingalpha | 6 months ago
Getinge AB (publ) (GNGBY) Q3 2025 Earnings Call Transcript

Getinge AB (publ) (GNGBY) Q3 2025 Earnings Call Transcript

Getinge AB (publ) (OTCPK:GNGBY) Q3 2025 Earnings Call October 21, 2025 4:00 AM EDT Company Participants Mattias Perjos - CEO, President & Director Agneta Palmer - Chief Financial Officer Conference Call Participants Kristofer Liljeberg-Svensson - DNB Carnegie, Research Division Mattias Vadsten - SEB, Research Division Sten Gustafsson - ABG Sundal Collier Holding ASA, Research Division Erik Cassel - Danske Bank A/S, Research Division Ludvig Lundgren - Nordea Markets, Research Division Ludwig Germunder - Handelsbanken Capital Markets AB, Research Division Presentation Operator Welcome to the Getinge Q3 Report 2025 Presentation. [Operator Instructions] Now I will hand the conference over to the speakers CEO, Mattias Perjos; and CFO, Agneta Palmer.

Seekingalpha | 9 months ago

Getinge AB Unsponsored ADR (GTN0) FAQ

What is the stock price today?

The current price is €21.60.

On which exchange is it traded?

Getinge AB Unsponsored ADR is listed on XMUN.

What is its stock symbol?

The ticker symbol is GTN0.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.67%.

What is its market cap?

As of today, the market cap is 4.82B.

Has Getinge AB Unsponsored ADR ever had a stock split?

No, there has never been a stock split.

Getinge AB Unsponsored ADR Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mattias Perjos CEO
XMUN Exchange
US37427X1046 ISIN
SE Country
12,118 Employees
23 Apr 2026 Last Dividend
- Last Split
- IPO Date

Overview

Getinge AB (publ) is a global provider of products and solutions targeted at improving efficiencies and outcomes in operating rooms, intensive-care units, sterilization departments, and more. Established in 1904 and based in Gothenburg, Sweden, the company enriches healthcare facilities worldwide through its three operative segments: Acute Care Therapies, Life Science, and Surgical Workflows. It is dedicated to offering a wide range of medical technologies and services, catering to the critical areas of patient care and scientific processes. Getinge stands out for its comprehensive product portfolio that addresses complex healthcare challenges, aiming for innovation in patient care and clinical results. The company extends its reach through an extensive network of sales companies and partners across the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions, ensuring its solutions are accessible globally.

Products and Services

  • Extracorporeal membrane oxygenation (ECMO), mechanical ventilation, and mechanical circulatory support:

    These are life-saving therapies for patients in critical conditions, offering support for heart and lung functions.

  • Advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions:

    Comprehensive patient monitoring and management systems designed for the intensive care environment, improving patient flow and care efficiency.

  • Surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions:

    Essential tools and technologies for cardiac surgery, enhancing surgical outcomes and patient recovery.

  • Operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions:

    State-of-the-art solutions for the operating room, facilitating better coordination, safety, and efficiency during surgical procedures.

  • Pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices:

    Comprehensive infection control solutions that ensure the cleanliness and sterility of medical devices and environments, backed by advanced connectivity for seamless operations.

  • Bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers:

    Advanced solutions supporting the life science industry in drug development and manufacturing processes with a focus on sterility and containment.

  • Vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions:

    Equipment and systems designed for research labs and bioprocessing facilities, ensuring safe handling of materials and sterility for bioprocessing applications.

Contact Information

Address: Lindholmspiren 7A
Phone: 46 1 03 35 00 00